These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic Antigens. Hall CE; Hagan LM; Bergmann-Leitner E; Tosh DM; Bennett JW; Regules JA; Chuang I; Angov E; Dutta S; Chattopadhyay D; Yadava A Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30559218 [TBL] [Abstract][Full Text] [Related]
13. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Clyde DF Am J Trop Med Hyg; 1975 May; 24(3):397-401. PubMed ID: 808142 [TBL] [Abstract][Full Text] [Related]
14. Distinct immune responses associated with vaccination status and protection outcomes after malaria challenge. Oyong DA; Duffy FJ; Neal ML; Du Y; Carnes J; Schwedhelm KV; Hertoghs N; Jun SH; Miller H; Aitchison JD; De Rosa SC; Newell EW; McElrath MJ; McDermott SM; Stuart KD PLoS Pathog; 2023 May; 19(5):e1011051. PubMed ID: 37195999 [TBL] [Abstract][Full Text] [Related]
15. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies. Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525 [TBL] [Abstract][Full Text] [Related]
16. Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites. Schats R; Bijker EM; van Gemert GJ; Graumans W; van de Vegte-Bolmer M; van Lieshout L; Haks MC; Hermsen CC; Scholzen A; Visser LG; Sauerwein RW PLoS One; 2015; 10(5):e0124243. PubMed ID: 25933168 [TBL] [Abstract][Full Text] [Related]
17. Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2. Dejon-Agobe JC; Ateba-Ngoa U; Lalremruata A; Homoet A; Engelhorn J; Nouatin OP; Edoa JR; Fernandes JF; Esen M; Mouwenda YD; Betouke Ongwe EM; Massinga-Loembe M; Hoffman SL; Sim BKL; Theisen M; Kremsner PG; Adegnika AA; Lell B; Mordmüller B Clin Infect Dis; 2019 Sep; 69(8):1377-1384. PubMed ID: 30561539 [TBL] [Abstract][Full Text] [Related]